期刊文献+

酮咯酸氨丁三醇联合舒芬太尼用于直肠癌根治术术后镇痛的研究 被引量:13

Effect of ketorolac tromethamine being used on patients who undergo radical resection of rectal carcinoma along with sufentanil
下载PDF
导出
摘要 目的观察酮咯酸氨丁三醇联合舒芬太尼用于直肠癌根治术术后镇痛的效果及安全性。方法选择择期行直肠癌根治术的患者40例。将患者随机分为A、B 2组,每组20例。常规全麻诱导和维持,术闭拔管后,分别连接含有不同药物的静脉自控镇痛(PCIA)泵。A组PCIA泵内应用舒芬太尼1.5μg/kg,酮咯酸氨丁三醇3.0mg/kg,雷莫司琼0.6mg;B组:舒芬太尼2.5μg/kg,雷莫司琼0.6mg,为对照组。记录启动PCIA泵即刻(T0)、1h(T1)、2h(T2)、4h(T3)、8h(T4)、12h(T5)、24h(T6)36h(T7)、48h(T8)的视觉模拟疼痛(VAS)评分、镇静评分(Ramsay评分)、血压(BP)、心率(HR)、呼吸频率(RR)、脉搏血氧饱和度(SpO2)的变化及术后镇痛期间恶心、呕吐、呼吸抑制、嗜睡、异常出血等副作用的发生情况,另外比较2组PCIA泵按压次数。结果 (1)疼痛评分2组患者T1、T2时刻VAS评分较T0有所增高,但无统计学意义(P>0.05),T3-T8VAS呈平稳降低趋势;组间比较无差异(P>0.05)。(2)镇静评分A组患者在T1-T8时间点镇静评分无差异(P>0.05),B组在T2、T3、T4时刻的镇静评分比A组相应数据显著升高(P<0.05)。(3)PCIA泵按压次数A、B组各时间点数据无差异(P>0.05)。(4)副作用发生频率B组较A组术后恶心、嗜睡的发生率显著升高(P<0.01)。结论直肠癌根治术后应用舒芬太尼1.5μg/kg,酮咯酸氨丁三醇3.0mg/kg配制的PCIA泵进行镇痛,既能达到理想镇痛效果,又能有效减少不良反应的发生。 Objective To observe the safety and the effect of ketorolac tromethamine along with sufentanil as a postoperative patient-controlled intravenous analgesia,which is used by the patients who undergo a radical resection of rectal carcinoma.Methods A total of 40 patients undergoing a radical resection of rectal carcinoma were randomly divided into two groups,20 cases in each.Group A use a PCIA with sufentanil 1.5 μg/kg,ketorolac tromethamine 3.0 mg/kg, ramosetron 0.6 mg after sugery;and Group B use a PCIA with sufentanil 2.5 μg/kg,ramosetron 0.6 mg.Start the PCIA instantly when the patient awake.Record the blood pressure(BP),heart rate(HR),respiratory rate(RR),pulse oxygen saturation(SpO2 ),and side effects,such as nausea,vomiting,respiratory inhibition,bleeding at the following moments:instantly(T0 ),1 h(T1 ),2 h(T2 ),4 h(T3 ),8 h(T4 ),12 h(T5 ),24 h(T6 ),36 h(T7 ),48 h(T8 )after the operation.Record the intensity of pain using the VAS,the intensity of sedation using Ramsay.Count the numbers of pressing.Results (1)VAS scores:the scores at T1 and T2 were higher than the scores at T0 in Group A and Group B,but there is no significant difference,then after the T2 the scores were lower and lower;there is no significant difference between Group A and B(P 〉0.05).(2)Intensity of sedation:the scores of Group B at T2 ,T3 ,T4 were higher than Group A(P 〈0.05).(3)Incidence of side effects:incidences of nausea and drowsiness are higher in Group B than Group A(P〈0.05).Vomiting,respiratory inhibition and bleeding don’t happen to all patients.(4)Times of pressing:there is no difference between Group A and B(P 〉0.05).Conclusion Using PCIA with ketorolac tromethamine 3.0 mg/kg and sufentanil 1.5 μg/kg has great analgesia effect and less side effects after a radical resection of rectal carcinoma.
出处 《中国实验诊断学》 2015年第5期731-734,共4页 Chinese Journal of Laboratory Diagnosis
关键词 酮咯酸氨丁三醇 舒芬太尼 术后镇痛 ketorolac tromethamine sufentanil postoprative analgesia
  • 相关文献

参考文献7

二级参考文献16

  • 1王迪芬,刘兴敏.胸膜间阻滞用于胸外科疾病的镇痛治疗[J].国外医学(麻醉学与复苏分册),1994,15(2):116-117. 被引量:1
  • 2Aubrun F, Salvi N, Coriat P, et al. Sex - and Age -related differences in morphinerequirements for postoptative pain relief[ J]. Anesthesiology,2005,103 (66) : 156 - 160.
  • 3Petring OU, Dawson PJ, Blake DW, et al. Normal postoperative gastric emptying after orthopaedic surgery with spinal anaesthesia and i. m. ketorolac as the first postoperative analgesic [ J ]. Br J Anaesth, 1995,74: 257 - 260.
  • 4Berg J, Fellier H, Cristoph T. The analgesic NSAID tomoxieam inhibitis eyeloxygenase(cox) - 1/- 2, inducible nitric oxide synthase (INOS) ; and the formation of tnterleukin(il) - 6 in vitro[ J]. Inflamm Res 1999,48: 369 - 379.
  • 5[1]Oosterlinck W, Philp N H, Charig C, et al. A double-blind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic[J]. J Clin Pharmacol, 1990,30(4):336-341.
  • 6[2]Staquet M J. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain[J]. J Clin Pharmacol, 1989,29(11):1031-1036.
  • 7[3]Kathy M, McEvor G K. Ketorolac, an injectable nonnar-cotic analgesic[J]. Am J Hosp Pharm, 1991,48(1):168-169.
  • 8White PF.The changing role of non-opioiol analege ic techniques in the managem ent of postoperative pain[J].Anesth Analg,2005,101(9):5-22.
  • 9白念岳,程智刚,郭曲练,朱茂恩,王卡,赵黎丽.酮咯酸氨丁三醇与盐酸曲马多用于术后自控镇痛的效果比较[J].中国医师杂志,2007,9(9):1279-1280. 被引量:21
  • 10李仲廉.临床疼痛治疗学[M]天津科学技术出版社,1994.

共引文献19

同被引文献135

  • 1吕治全,闫东.丙泊酚与瑞芬太尼静吸复合麻醉对老年腹腔镜下胆囊切除术患者术后认知功能的影响[J].中国老年学杂志,2015,35(2):289-291. 被引量:105
  • 2高雁,邢玉英,李力兵,刘华琴,张加强.人工流产术患者瑞芬太尼靶控输注复合异丙酚的效应[J].中华麻醉学杂志,2005,25(6):472-473. 被引量:24
  • 3方祝英,韩丽红.静脉自控镇痛泵在骨折术后病人中的应用与护理[J].临床护理杂志,2007,6(1):35-36. 被引量:2
  • 4刘幸清,胡旭东,张文礼,等.地佐辛与芬太尼分别复合氯诺昔康在骨科肩关节镜手术后病人自控镇痛的临床应用[J].中国医师杂志,2011,2(z2):127-128.
  • 5Chen JY, Ko TL, Wen YR, et al. Opioid-sparing effects of ketorolacand its correlation with the recovery of postoperative bowel functionin colorectal surgery patients: a prospective randomized doubleblindedstudy[J]. The Clinical Journal of Pain, 2009, 25(6): 485-489.
  • 6Schlachta C, Burpee S, Fernandez C, et al. Optimizing recovery afterlaparoscopic colon surgery (ORAL-CS): effect of intravenousketorolac on length of hospital stay[J]. Surgical Endoscopy, 2007,21(12): 2212-2219.
  • 7Gikic M, Di Paolo ER, Pannatier A, et al . Evaluation of Physicochemical Incompatibilities during Parenteral Drug Administration in a Paediatric Intensive Care Unit [J]. Pharm World Sci, 2000, (22) : 88-91.
  • 8孟建.地佐辛联合酮咯酸氨丁三醇治疗肾绞痛[c].中华医学会急诊医学分会第17次全国急诊医学学术年会论文集,2014:652-652.
  • 9中国药典:四部[S].2015:114-115.
  • 10Tzu-Fu Lin, Feng-Sheng Lin, Wei-Han Chou, et al. Compatibility and Stability of Binary Mixtures of Ketorolac Tromethamine and Tramadol Hydrochloride Injection Concentrate and Diluted Infusion Solution[J]. Acta AnaesthesiolTaiwan, 2010, 48 (3) : 117-121.

引证文献13

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部